Real World Study of End-stage Liver Disease in China
Huashan Hospital
10,000 participants
Sep 1, 2019
OBSERVATIONAL
Conditions
Summary
The aims of this study are exploring the current situation of end-stage liver disease in China, and the optimization of diagnosis and treatment. Liver cirrhosis often accompanied by a series of complications. Therefore, it is necessary to standardize the diagnosis and treatment of liver cirrhosis and its complications. End-stage liver disease mainly refers to the late stage of liver disease caused by various chronic liver damage. Its main feature is that liver function can not meet the physiological needs of human body. This study is a single-center, prospective and observational real-world study aimed at investigating and analyzing the current diagnosis and treatment of liver cirrhosis and end-stage liver disease in China.
Eligibility
Inclusion Criteria2
- Informed consent of patients.
- Diagnosis of any of the following diseases: acute decompensation of cirrhosis, chronic and acute liver failure, chronic liver failure and hepatocellular carcinoma (stage III-IV)
Exclusion Criteria5
- HIV antibody positive and AIDS patients
- Serious psychiatric history, especially depression. Severe mental illness is defined as major depression or psychosis, suicide attempts, hospitalization due to mental illness or a period of disability due to mental illness.
- Patients with serious diseases of heart, lung, kidney, brain, blood and other important organs.
- Patients with other malignant tumors (excluding those cured).
- Pregnant, lactating women or women of childbearing age who are ready to conceive.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
No intervation
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04037995